An experimental peptide could block Covid-19
MIT chemists are testing a protein fragment that may inhibit coronaviruses’ ability to enter human lung cells.
MIT chemists are testing a protein fragment that may inhibit coronaviruses’ ability to enter human lung cells.
Clinical and design considerations will be published online; goal is to support rapid scale-up of device production to alleviate hospital shortages.
Repurposing a drug used for blood clots may help Covid-19 patients in danger of respiratory failure, researchers suggest.
With thousands now working and learning off-campus, the Institute aims to consolidate its footprint and conserve resources.
Area hospitals in need of PPE look to university labs and departments for donations.
Lincoln Laboratory researchers explore the impact of technology that detects a person's exposure to disease-causing pathogens before symptoms manifest.
Findings could help researchers design drugs to treat influenza B infections.
A new coronavirus first detected in Wuhan, China, poses no identified risk to the MIT community at this time.
MIT spinoff is changing the way mosquito-borne illnesses are diagnosed and aims to influence how public health officials react to disease outbreaks.
The unusual characteristics of these abundant, bacteria-killing viruses could lead to evolutionary insights.
Asian flu strains can enter North America through Alaska, study finds.
Immune molecules in infected mothers tied to brain and behavior abnormalities in offspring.
Public Event on Dec. 8 will explore hacks for rapid diagnostic devices.
Engineered viruses could combat human disease and improve food safety.